Liliana Ladner

Ms. Liliana Ladner

Virginia Tech Carilion School of Medicine, Roanoke, Virginia, USA
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 October 2023 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
ACAlison Cash
Alison Cash
CJCaroline de Jager
Caroline de Jager
TBThomas Brickler
Thomas Brickler
ESEman Soliman
Eman Soliman
Liliana LadnerLiliana Ladner
Liliana Ladner
MTMichelle Theus
Michelle Theus
Neurobiological consequences of traumatic brain injury (TBI) result from a complex interplay of secondary injury responses and sequela that mediates chronic disability. Endothelial cells are important regulators of the cerebrovascular response to TBI. Our work demonstrates that genetic deletion of endothelial cell (EC)-specific EPH receptor A4 (EphA4) using conditionalEphA4f/f/Tie2-CreandEphA4f/f/VE-Cadherin-CreERT2knockout (KO) mice promotes blood–brain barrier (BBB) integrity and tissue protection, which correlates with improved motor function and cerebral blood flow recovery following controlled cortical impact (CCI) injury. scRNAseq of capillary-derived KO ECs showed increased differential gene expression of BBB-related junctional and actin cytoskeletal regulators, namely, A-kinase anchor protein 12,Akap12, whose presence at Tie2 clustering domains is enhanced in KO microvessels. Transcript and protein analysis of CCI-injured whole cortical tissue or cortical-derived ECs suggests that EphA4 limits the expression of Cldn5, Akt, and Akap12 and promotes Ang2. Blocking Tie2 using sTie2-Fc attenuated protection and reversed Akap12 mRNA and protein levels cortical-derived ECs. Direct stimulation of Tie2 using Vasculotide, angiopoietin-1 memetic peptide, phenocopied the neuroprotection. Finally, we report a noteworthy rise in soluble Ang2 in the sera of individuals with acute TBI, highlighting its promising role as a vascular biomarker for early detection of BBB disruption. These findings describe a contribution of the axon guidance molecule, EphA4, in mediating TBI microvascular dysfunction through negative regulation of Tie2/Akap12 signaling.

7 July 2023 in World Neurosurgery
Verified
Journal Article
Closed access
SASrijan Adhikari
Srijan Adhikari
ABAbhishek S. Bhutada
Abhishek S. Bhutada
Liliana LadnerLiliana Ladner
Liliana Ladner
JCJoshua Aaron Cuoco
Joshua Aaron Cuoco
JEJohn J. Entwistle
John J. Entwistle
CRCara M. Rogers
Cara M. Rogers

25 October 2022 in Cells
Verified
Journal Article
Open access
PDF file
JMJatia Mills
Jatia Mills
Liliana LadnerLiliana Ladner
Liliana Ladner
ESEman Soliman
Eman Soliman
JLJohn Leonard
John Leonard
PMPaul Morton
Paul Morton
MTMichelle Theus
Michelle Theus
Neurological disorders are highly prevalent and often lead to chronic debilitating disease. Neuroinflammation is a major driver across the spectrum of disorders, and microglia are key mediators of this response, gaining wide acceptance as a druggable cell target. Moreover, clinical providers have limited ability to objectively quantify patient-specific changes in microglia status, which can be a predictor of illness and recovery. This necessitates the development of diagnostic biomarkers and imaging techniques to monitor microglia-mediated neuroinflammation in coordination with neurological outcomes. New insights into the polarization status of microglia have shed light on the regulation of disease progression and helped identify a modifiable target for therapeutics. Thus, the detection and monitoring of microglia activation through the inclusion of diagnostic biomarkers and imaging techniques will provide clinical tools to aid our understanding of the neurologic sequelae and improve long-term clinical care for patients. Recent achievements demonstrated by pre-clinical studies, using novel depletion and cell-targeted approaches as well as single-cell RNAseq, underscore the mechanistic players that coordinate microglial activation status and offer a future avenue for therapeutic intervention.

13 May 2024 in World Neurosurgery
Verified
Journal Article
Closed access
JLJaims Lim
Jaims Lim
AAAlexander O. Aguirre
Alexander O. Aguirre
ABAmmad A. Baig
Ammad A. Baig
BLBennett R. Levy
Bennett R. Levy
Liliana LadnerLiliana Ladner
Liliana Ladner
ELElad I. Levy
Elad I. Levy

8 December 2023 in World Neurosurgery
Verified
Journal Article
Closed access
Liliana LadnerLiliana Ladner
Liliana Ladner
ABAbhishek S. Bhutada
Abhishek S. Bhutada
SASrijan Adhikari
Srijan Adhikari
JCJoshua Aaron Cuoco
Joshua Aaron Cuoco
JEJohn J. Entwistle
John J. Entwistle
EMEric A. Marvin
Eric A. Marvin

13 December 2024 in Journal of Neurotrauma
Verified
Journal Article
Closed access
Liliana LadnerLiliana Ladner
Liliana Ladner
TSTyler Shick
Tyler Shick
SASrijan Adhikari
Srijan Adhikari
EMEric Marvin
Eric Marvin
JWJustin Louis Weppner
Justin Louis Weppner
AKAnita Kablinger
Anita Kablinger
Traumatic brain injury (TBI) affects over 48 million people worldwide each year. Suicide is common in TBI, and there are several known contributing factors, including severe TBI, depression, alcohol use, and male sex. Impulsivity, or the tendency to act quickly with little thought, may be an early predictor of suicidality following TBI. The purpose of this study was to evaluate the risk of suicidality in patients with a prior history of impulsivity following a TBI. Using de-identified electronic health records from the TriNetX U.S. Collaborative Network with Natural Language Processing, three cohorts were generated: the impulsivity TBI cohort (I+TBI+) included subjects with a diagnosis of impulsivity before a diagnosis of TBI; the no impulsivity TBI cohort (I−TBI+) included patients with TBI but no impulsivity; the impulsivity no TBI cohort (I+TBI−) included patients with impulsivity but TBI. Two analyses were conducted, including analysis 1 (impulsivity TBI vs. no impulsivity TBI) and analysis 2 (impulsivity TBI vs. impulsivity no TBI). Patients were 1:1 matched by age, sex, race, ethnicity, psychiatric diagnoses, and antidepressant use. Outcomes included a diagnosis of self-harm, suicidal ideation, or a suicide attempt within 1 year after the index event. The all-time incidence of each outcome was assessed across different age categories. The chi-square test (categorical variables) and t -test (numerical variables) were used to assess for differences between groups. A total of 1,292,776 patients with TBI were identified in the study. After 1:1 matching, there were 20,694 patients (mean [standard deviation, SD] age, 48.1 [21.8]; 8,424 females [40.7%]) with impulsivity and TBI (I+TBI+), 1,272,082 patients (mean [SD] age, 46.0 [23.1]; 562,705 females [44.2%]) with TBI alone (I−TBI+), and 90,669 patients (mean [SD] age, 43.7 [22.6]; 45,188 females [49.8%]) with impulsivity alone (I+TBI−). Within the first year after a TBI, patients with impulsivity were more likely to exhibit self-harm ( p < 0.001), suicidal ideation ( p < 0.001), or a suicide attempt ( p < 0.001). Compared with patients with TBI without impulsivity, those with impulsivity had a 4-fold increase in the incidence of self-harm (2.81% vs. 0.63%), an 8-fold increase in suicidal ideation (52.42% vs. 6.41%), and a 21-fold increase in suicide attempts (32.02% vs. 1.50%). This study suggests that impulsivity diagnosed before a TBI may increase the risk of post-traumatic suicidality, with a 4-fold increased risk of self-harm, an 8-fold increased risk of suicidal ideation and a 21-fold increased risk of suicide attempts. This characterizes a group of at-risk individuals who may benefit from early psychiatric support and targeted interventions following a TBI.